Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer.
Li Y, Wu S, Zhao Y, Dinh T, Jiang D, Selfridge JE, Myers G, Wang Y, Zhao X, Tomchuck S, Dubyak G, Lee RT, Estfan B, Shapiro M, Kamath S, Mohamed A, Huang SC, Huang AY, Conlon R, Krishnamurthi S, Eads J, Willis JE, Khorana AA, Bajor D, Wang Z. Li Y, et al. Among authors: tomchuck s. J Clin Invest. 2024 Jan 9;134(5):e175031. doi: 10.1172/JCI175031. J Clin Invest. 2024. PMID: 38194275 Free PMC article.
Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
Choi SH, Myers J, Tomchuck S, Bonner M, Eid S, Kingsley D, VanHeyst K, Kim SJ, Kim BG, Huang AY. Choi SH, et al. Among authors: tomchuck s. Res Sq [Preprint]. 2023 Apr 3:rs.3.rs-2709282. doi: 10.21203/rs.3.rs-2709282/v1. Res Sq. 2023. Update in: Cancer Commun (Lond). 2024 Aug;44(8):884-888. doi: 10.1002/cac2.12589 PMID: 37066414 Free PMC article. Updated. Preprint.
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
Choi SH, Myers JT, Tomchuck SL, Bonner M, Eid S, Kingsley DT, VanHeyst KA, Kim SJ, Kim BG, Huang AY. Choi SH, et al. Among authors: tomchuck sl. Cancer Commun (Lond). 2024 Aug;44(8):884-888. doi: 10.1002/cac2.12589. Epub 2024 Jul 6. Cancer Commun (Lond). 2024. PMID: 38970391 Free PMC article. No abstract available.
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activation.
Chen YF, Ghazala M, Friedrich RM, Cordova BA, Petroze FN, Srinivasan R, Allan KC, Yan DF, Sax JL, Carr K, Tomchuck SL, Fedorov Y, Huang AY, Desai AB, Adams DJ. Chen YF, et al. Among authors: tomchuck sl. Nat Chem Biol. 2024 Oct;20(10):1260-1271. doi: 10.1038/s41589-024-01586-5. Epub 2024 Mar 25. Nat Chem Biol. 2024. PMID: 38528120
Piezo1 facilitates optimal T cell activation during tumor challenge.
Abiff M, Alshebremi M, Bonner M, Myers JT, Kim BG, Tomchuck SL, Santin A, Kingsley D, Choi SH, Huang AY. Abiff M, et al. Among authors: tomchuck sl. Oncoimmunology. 2023 Nov 22;12(1):2281179. doi: 10.1080/2162402X.2023.2281179. eCollection 2023. Oncoimmunology. 2023. PMID: 38126029 Free PMC article.
19 results